Background: Genetic engineering of microorganisms has become a common practice to establish microbial cell factories for a wide range of compounds. Ethyl acetate is an industrial solvent that is used in several applications, mainly as a biodegradable organic solvent with low toxicity. While ethyl acetate is produced by several natural yeast species, the main mechanism of production has remained elusive until the discovery of Eat1 in . Unlike other yeast alcohol acetyl transferases (AATs), Eat1 is located in the yeast mitochondria, suggesting that the coding sequence contains a mitochondrial pre-sequence. For expression in prokaryotic hosts such as , expression of heterologous proteins with eukaryotic signal sequences may not be optimal.

Results: Unprocessed and synthetically truncated eat1 variants of and have been compared in vitro regarding enzyme activity and stability. While the specific activity remained unaffected, half-life improved for several truncated variants. The same variants showed better performance regarding ethyl acetate production when expressed in

Conclusion: By analysing and predicting the N-terminal pre-sequences of different Eat1 proteins and systematically trimming them, the stability of the enzymes in vitro could be improved, leading to an overall improvement of in vivo ethyl acetate production in . Truncated variants of could therefore benefit future engineering approaches towards efficient ethyl acetate production.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168974PMC
http://dx.doi.org/10.1186/s13068-020-01711-1DOI Listing

Publication Analysis

Top Keywords

ethyl acetate
24
acetate production
16
truncated variants
8
ethyl
6
acetate
6
eat1
5
production
5
eat treat
4
treat engineering
4
engineering mitochondrial
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!